help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-96-3-618
Endocrinology Vol. 96, No. 3 618-624
Copyright © 1975 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WELSH, M. J.
Right arrow Articles by WIEBE, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WELSH, M. J.
Right arrow Articles by WIEBE, J. P.

Rat Sertoli Cells: A Rapid Method for Obtaining Viable Cells1

MICHAEL J. WELSH and JOHN P. WIEBE

Regulatory Mechanisms Laboratory, Department of Zoology, University of Western Ontario London, Ontario, Canada

Abstract

A method is described for obtaining populations of viable Sertoli cells from rat testes. Minced whole testes from rats of 15 to 29 days of age are sequentially treated with collagenase and pancreatin. The resulting suspension of cells is sedimented through a sucrose density gradient. Preparations are produced consisting of from 60% to 82% Sertoli cells, an enrichment of 2 to 5 times the proportion of Sertoli cells in whole testes of these ages. The preparations are free of interstitial cells, are essentially free of peritubular cells and contain reduced numbers of germinal cells; the main contaminating cell types are spermatogonia and spermatocytes. The Sertoli cells are considered to be 95% viable by their ability to exclude trypan blue and by subsequent culturing in vitro. The entire procedure requires 3 h. Maintenance of the Sertoli-enriched fraction in modified Eagle's minimal essential medium temporarily at 41 C allows preparations of Sertoli cell monolayer cultures consisting of 95%–98% Sertoli cells within 3 days. (Endocrinology 96: 618, 1975)

Footnotes

1 This research was supported by NRC grant No. A6865 and by a U.S. National Science Foundation Graduate Fellowship to M.J.W.

Received September 5, 1874.




This article has been cited by other articles:


Home page
ReproductionHome page
P F Oliveira, M Sousa, A Barros, T Moura, and A Rebelo da Costa
Intracellular pH regulation in human Sertoli cells: role of membrane transporters
Reproduction, February 1, 2009; 137(2): 353 - 359.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. S. Devi, K. Sarda, B. Stephen, P. Nagarajan, and S. S. Majumdar
Follicle-Stimulating Hormone-Independent Functions of Primate Sertoli Cells: Potential Implications in the Diagnosis and Management of Male Infertility
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1062 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
X. Yu, J. S. Sidhu, S. Hong, and E. M. Faustman
Essential Role of Extracellular Matrix (ECM) Overlay in Establishing the Functional Integrity of Primary Neonatal Rat Sertoli Cell/Gonocyte Co-cultures: An Improved In Vitro Model for Assessment of Male Reproductive Toxicity
Toxicol. Sci., April 1, 2005; 84(2): 378 - 393.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. J. Heindel and K. A. Treinen
Physiology of the Male Reproductive System: Endocrine, Paracrine and Autocrine Regulation
Toxicol Pathol, February 1, 1989; 17(2): 411 - 445.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1975 by The Endocrine Society